How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Showcase your company news with guaranteed exposure both in print and online For 28 years Triangle Business Journal has been saluting outstanding women leaders in the Triangle… Join us for an engaging ...

Showcase your company news with guaranteed exposure both in print and online What is next for the Triangle real estate market? We explore the challenges and opportunities… For 28 years Triangle ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...